Evidence mapPaperPMID 41527700Full record

ArticleDiabetes, obesity & metabolism2026

Reallocating morning physical activity to later-day activity and its association with type 2 diabetes incidence: The Maastricht Study.

Marvin Y Chong, Simone J P M Eussen, Jeroen H P M van der Velde, Bastiaan E de Galan, Hans H C M Savelberg, Hans Bosma, Martijn J L Bours, Matty P Weijenberg, Annemarie Koster

Abstract read
In one paragraph

Article in Diabetes, obesity & metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Marvin Y ChongDepartment of Epidemiology, CARIM Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands.ORCID 0000-0002-4179-6290
Simone J P M EussenDepartment of Epidemiology, CARIM Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands.
Jeroen H P M van der VeldeDepartment of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
Bastiaan E de GalanDepartment of Internal Medicine, Maastricht University Medical Center+ (MUMC+), Maastricht, The Netherlands.
Hans H C M SavelbergDepartment of Nutrition and Movement Science, NUTRIM Institute of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, The Netherlands.
Hans BosmaDepartment of Social Medicine, CAPHRI Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands.
Martijn J L BoursDepartment of Epidemiology, GROW Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.
Matty P WeijenbergDepartment of Epidemiology, GROW Research Institute for Oncology and Reproduction, Maastricht University, Maastricht, The Netherlands.
Annemarie KosterDepartment of Social Medicine, CAPHRI Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands.

Funding

CAPHRI Care and Public Health Research Institute (Maastricht, The Netherlands)CARIM Cardiovascular Research Institute Maastricht (Maastricht, The Netherlands)European Regional Development Fund via OP-Zuid, the Province of Limburg, the Dutch Ministry of Economic Affairs 31O.041Novo Nordisk Farma B.V. (Alphen aan den Rijn, The Netherlands) and Sanofi-Aventis Netherlands B.V. (Gouda, The Netherlands)NUTRIM Institute of Nutrition and Translational Research in Metabolism (Maastricht, The Netherlands)Stichting Annadal (Maastricht, The Netherlands), Health Foundation Limburg (Maastricht, The Netherlands) and by unrestricted grants from Janssen-Cilag B.V. (Tilburg, The Netherlands)Stichting De Weijerhorst (Maastricht, The Netherlands)the Cardiovascular Center (CVC, Maastricht, The Netherlands)the Pearl String Initiative Diabetes (Amsterdam, The Netherlands)
6 · The paper itself

Abstract

aimsThe timing of physical activity may influence metabolic health through interactions with circadian rhythms, yet its role in type 2 diabetes mellitus (T2DM) development is unclear. We investigated associations between time-of-day-specific physical activity and incident T2DM, and whether theoretically reallocating activity from morning to later in the day was associated with changes in T2DM risk. MATERIALS AND

methodsWe included 4615 participants from The Maastricht Study cohort without diabetes (age 59.2 ± 8.6 years; 56.3% women). Device-based physical activity was measured over 7 days using activPAL monitors and classified into light-intensity physical activity (LPA) and moderate-to-vigorous intensity physical activity (MVPA), for morning (06:00-11:59 AM), afternoon (12:00-17:59 PM), evening (18:00-23:59 PM) and night (00:00-05:59 AM). Incident T2DM was assessed during a median 8.2-year follow-up. Cox proportional hazard and isotemporal substitution models were used, adjusted for sociodemographic and lifestyle factors, including diet, employment and sleep duration.

resultsDuring follow-up, 168 participants (3.6%) developed T2DM. Each additional 10 min/day of afternoon LPA or MVPA was associated with lower T2DM risk (LPA: hazard ratio [HR] 0.82, 95% confidence interval [CI] 0.70-0.97; MVPA: HR 0.85, 95% CI 0.72-1.00). Evening MVPA was also inversely associated with T2DM risk (0.65; 0.45-0.93), whereas night-time MVPA was associated with an increased risk (3.64; 1.30-10.17). No significant associations were found of morning LPA and MVPA or evening and night LPA with T2DM incidence. Substitution analyses indicated that reallocating 10 min of morning LPA to afternoon LPA (HR 0.71; 0.54-0.95) or morning MVPA to evening MVPA (HR: 0.64; 0.43-0.96) was associated with a lower T2DM risk, while no other significant associations were observed.

conclusionsLater-day physical activity, particularly in the afternoon, was associated with a lower incidence of T2DM, independent of intensity. This highlights the potential relevance of activity timing in relation to T2DM incidence.

Indexed as

Circadian RhythmDiabetes Mellitus, Type 2ExerciseAgedChronotypeFemaleFollow-Up StudiesHumansIncidenceMaleMiddle AgedNetherlandsRisk FactorsTime Factorscohort studyincident type 2 diabetesisotemporal substation modelslight‐intensity physical activitymoderate‐to‐vigorous intensity physical activityphysical activity timing

Identifiers

PMID41527700
PMCPMC12992169

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.